openPR Logo
Press release

Global Graves Disease Treatment Market­ 2019:Analysis By ALLERGAN, Novartis AG, Merck & Co., Inc, Sanofi, Pfizer Inc, AbbVie Inc, Mylan N.V, Apitope, Merck KGaA & Others

10-18-2019 12:55 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Graves disease treatment market

Global Graves disease treatment market

The Graves disease treatment report endows with current and upcoming technical and financial details of the industry to 2025 and hence proves to be a valuable source of information. The report can be accessible to the users in the form of PDF or spreadsheet. Moreover, PPT format can also be offered depending upon client’s requirement. Further, the statistical and numerical data including facts and figures are characterized very properly with the help of charts, tables or graphs. The data and information cited in this Graves disease treatment report is very reliable as it is drawn only from the valuable and genuine resources.

Global Graves disease treatment market­ is expected to grow at a steady CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the rise in number of patients with thyroid disorders, favorable reimbursement policies for treatment and increase in awareness about the complications associated with thyroid disorders and rising investment in the research & development of treatments for Hashimoto’s thyroiditis is expected to drive the market.

Key Market Players:

The key market players in the global Graves disease treatment market­ are Abbott, GlaxoSmithKline plc, ALLERGAN, Novartis AG, Merck & Co., Inc, Sanofi, Pfizer Inc, AbbVie Inc, Mylan N.V, Apitope, Merck KGaA, Amgen Inc, , Horizon Therapeutics plc, Medtronic, Immunovant, Inc, among others

Ask For Complimentary Sample PDF| Request At https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-graves-disease-treatment-market

Competitive Analysis:

Global Graves disease treatment market­ is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Graves disease treatment market ­for Global Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Drivers

High prevalence of autoimmune diseases such as Grave’s disease and Hashimoto’s thyroiditis is driving the market growth

Various national health programs related to thyroid disease that raise awareness regarding such diseases further boosts the growth of this market

Favorable reimbursement policies for the treatment

Increasing iodine disorder and thyroid tumors screening is also fueling the market growth

Market Restraints

High costs associated with the treatment and the usage of alternative medicines for the treatment of thyroid disorders is hindering the market growth

Side-effects associated with the current medication also restricts the market growth

Stringent government regulations is hampering the market growth

Table of Contents

1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type

View detailed table of content here https://www.databridgemarketresearch.com/toc/?dbmr=global-graves-disease-treatment-market

Segmentation: Global Graves Disease Treatment Market­

By Mechanism of Action Type

Anti-thyroid Agents

Beta Blockers

Corticosteroids

Others

By Drugs

Propylthiouracil

Methimazole

Propranolol

Prednisone

Others

By Diagnosis

Physical Exam

Blood Test

Radioactive Iodine Uptake Test

Ultrasound

Imaging Tests

By Treatment

Medication

Radioactive Iodine Therapy

Surgery

Others

By Route of Administration

Oral

Intravenous

Others

By Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

By End-Users

Hospitals

Homecare

Specialty Clinics

Others

By Geography

North America

Europe

Asia-Pacific

South America

Middle East & Africa

Key Developments in the Market

In June 2019, Horizon Therapeutics plc is developing teprotumumab, a complex protein that works by inhibiting the insulin-like growth factor I receptor (IGF-1R) for the treatment of Graves disease, currently ongoing in phase lll of OPTIC l trial. With this development the company provides better solution for the treatment of graves disease

In June 2019, Apitope is developing a novel drug ATX-GD-59, a peptide mixture of two different, highly soluble apitopes derived from TSH-receptor for the treatment of Graves disease currently ongoing in phase l clinical trial. If approved it will become the first innovative treatment in more than 60 years and will provide potential treatment to target the immunological basis of Graves’ disease

Inquiry For Customize Report With Discount at https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-graves-disease-treatment-market

Reasons to Purchase this Report

Current and future of global Graves disease treatment market­ outlook in the developed and emerging markets.

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

Regions/Countries that are expected to witness the fastest growth rates during the forecast period.

The latest developments, market shares, and strategies that are employed by the major market players.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Graves Disease Treatment Market­ 2019:Analysis By ALLERGAN, Novartis AG, Merck & Co., Inc, Sanofi, Pfizer Inc, AbbVie Inc, Mylan N.V, Apitope, Merck KGaA & Others here

News-ID: 1852409 • Views: 530

More Releases from Data Bridge Market Research

Viral Clearance Market 2020 Competitive Insights, Trends and Demand Growth to 20 …
Viral clearance is stated as the removal of contaminated viral by chromatography technique. The development process for monoclonal antibodies, blood-derived product, glycoprotein, and recombinant protein. To ensure that therapeutic drugs derived from certain sources are fully rid of any viral contamination, these protein solutions undergo viral clearance to inactivate or remove viral materials. Viral Clearance Market is expected to rise from its initial estimated value of USD 517million in 2016 to
Global Vaccine Adjuvants Market Detail Analysis focusing on Key Players like Inv …
The Global Vaccine Adjuvants Market document offers an in-depth investigation of the market driving factors, opportunities, restraints, and challenges for obtaining the crucial insight of the market. Such brilliant report has been prepared by a team of enthusiastic analysts, skilled researchers and experienced forecasters who work meticulously for the same. Large scale Global Vaccine Adjuvants Market research report presents intelligent solutions to the versatile business challenges and instigates an effortless
Uterine Polyps Drug Market is Thriving with Rising Latest Trends by 2027 | Top P …
Data Bridge Market Research has recently added a concise research on the Global Uterine Polyps Drug Market to depict valuable insights related to significant market trends driving the industry. The report features analysis based on key opportunities and challenges confronted by market leaders while highlighting their competitive setting and corporate strategies for the estimated timeline. The development plans, market risks, opportunities and development threats are explained in detail. The CAGR
Global Single-Cell Genome Sequencing Market is Thriving with Rising Latest Trend …
Global single-cell genome sequencing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of single-cell genome sequencing market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa. Single-Cell Genome Sequencing Market is expected to rise from its initial estimated

All 5 Releases


More Releases for Graves

Graves disease Market to Witness Exponential Growth by 2025
Graves’ disease is an autoimmune disorder that stimulates the thyroid gland to release excessive thyroid hormone, leading to hyperthyroidism. It is termed as Basedow’s disease in continental Europe and Graves’ disease in the U.S. In this disease, body’s immune system produces antibodies that help the thyroid gland to grow which in turn synthesizes abnormal levels of thyroid hormones causing hyperthyroidism. Graves’ disease is the most predominant cause of hyperthyroidism in the
Graves Diseases Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Graves Diseases - Pipeline Review, H1 2017, provides an overview of the Graves Diseases (Hormonal Disorders) pipeline landscape. Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism) . Symptoms include anxiety, weight loss, change in menstrual cycles, erectile dysfunction, bulging eyes and irregular heartbeat. Risk factors include family history, age, autoimmune disorders, smoking and pregnancy. Treatment
Global Clinical Trials Review for Graves Diseases, H2, 2017
"The Report Graves Diseases Global Clinical Trials Review, H2, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" ​Graves Diseases Global Clinical Trials Review, H2, 2017 Summary GlobalDatas clinical trial report, Graves Diseases Global Clinical Trials Review, H2, 2017" provides an overview of Graves Diseases clinical trials scenario. Get Sample copy of this Report @ ​https://www.marketresearchreports.biz/sample/sample/1335078 This report provides top line data relating to
Graves disease Market: Positive long-term growth outlook 2017 - 2025
Graves’ disease is an autoimmune disorder that stimulates the thyroid gland to release excessive thyroid hormone, leading to hyperthyroidism. It is termed as Basedow’s disease in continental Europe and Graves’ disease in the U.S. In this disease, body’s immune system produces antibodies that help the thyroid gland to grow which in turn synthesizes abnormal levels of thyroid hormones causing hyperthyroidism. Graves’ disease is the most predominant cause of hyperthyroidism in the
Latest research announces Graves Diseases - Pipeline Review, H2 2016
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graves Diseases Pipeline Review, H2 2016, provides an overview of the Graves Diseases (Hormonal Disorders) pipeline landscape. Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Symptoms include anxiety, weight loss, change in menstrual cycles, erectile dysfunction, bulging eyes and irregular heartbeat. Risk factors include family history, age, autoimmune disorders, smoking and pregnancy. Treatment
Global Autoimmune Drugs Market 2016: Graves Disease, Hashimotos Thyroidtis, Viti …
Latest industry research report on Autoimmune Drugs. Autoimmune disease is a condition which results in impaired function and the destruction of tissue, caused by an immune reaction. In autoimmune conditions abnormal antibodies are produced which attack the bodys own cells and tissues. The increasing incidences of autoimmune conditions like rheumatoid arthritis, type I diabetes, etc. have created the need for autoimmune drugs. Access Full Report @ http://www.intenseresearch.com/market-analysis/world-autoimmune-drugs-market-opportunities-and-forecasts-2014.html The rising awareness